Atika Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Atika Capital Management LLC

$874 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $4.27 Million - $9.98 Million	-59,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $640,356 - $911,574	5,100 Added 9.44%	59,100 $10.1 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $762,720 - $1.03 Million	-6,000 Reduced 10.0%	54,000 $7.58 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $799,800 - $1.48 Million	8,600 Added 16.73%	60,000 $9.62 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $1.7 Million - $2.71 Million	-20,600 Reduced 28.61%	51,400 $5.03 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $5.51 Million - $9.76 Million	72,000 New	72,000 $9.29 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $6.7 Million - $14.4 Million	-92,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$112.21 - $151.95 $224,420 - $303,900	2,000 Added 2.22%	92,000 $14 Million
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $1.27 Million - $1.8 Million	11,900 Added 15.24%	90,000 $10.7 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $87,588 - $133,884	-900 Reduced 1.14%	78,100 $8.52 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $807,170 - $1.13 Million	7,000 Added 9.72%	79,000 $12.8 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $1.79 Million - $3.84 Million	-25,000 Reduced 25.77%	72,000 $9.52 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $270,100 - $411,350	5,000 Added 5.43%	97,000 $7.19 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $381,120 - $454,000	-8,000 Reduced 8.0%	92,000 $5.12 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $3.57 Million - $4.72 Million	100,000	100,000 $4.54 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account